Duloxetinedraddress1 (Duloxetinedraddress1)
Duloxetine
Product Images NDC 50090-6040
11 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 50090-6040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Duloxetinedraddress2 (Duloxetinedraddress2)
Duloxetinedrfigure1 (Duloxetinedrfigure1)
A Kaplan-Meier survival curve showing the proportion of patients with relapse over time for Duloxetine versus placebo. The x-axis represents time, and the y-axis represents the proportion of patients with relapse. The graph compares relapse rates between the Duloxetine treatment group (solid line) and the placebo group (dashed line with circles).*
Duloxetinedrfigure2 (Duloxetinedrfigure2)
A line graph comparing relapse rates over time between Duloxetine and placebo treatments. The x-axis represents time in days from randomization to relapse, and the y-axis shows the proportion of patients experiencing relapse. The graph illustrates relapse proportions increasing over time for both treatments, with placebo showing a higher relapse proportion than Duloxetine.*
Duloxetinedrfigure3 (Duloxetinedrfigure3)
A line graph showing the percentage of patients improved versus percent improvement in pain from baseline for Duloxetine at doses of 60 mg BID, 60 mg QD, 20 mg QD, and placebo. The graph compares efficacy across these treatments, indicating patient response rates at various improvement thresholds.*
Duloxetinedrfigure4 (Duloxetinedrfigure4)
A line graph showing the percentage of patients improved versus percent improvement in pain from baseline. The graph compares three groups: Duloxetine 60mg BID, Duloxetine 60mg QD, and placebo, illustrating patient response to different dosing regimens versus placebo across varying levels of pain improvement.*
Duloxetinedrfigure7 (Duloxetinedrfigure7)
A line graph comparing the percentage of patients improved against the percent improvement in pain from baseline (Bocf), showing data for placebo and Duloxetine 60/120 mg once daily groups. The x-axis represents the percent improvement in pain, and the y-axis represents the percentage of patients improved.*
Duloxetinedrfigure8 (Duloxetinedrfigure8)
A line graph comparing the percentage of patients improved versus percent improvement in pain from baseline (BOCF) for Duloxetine 60 mg once daily and placebo. The x-axis shows percent improvement in pain, while the y-axis displays the percentage of patients improved, with two plotted lines representing placebo and Duloxetine treatment groups.*
Duloxetinedrfigure9 (Duloxetinedrfigure9)
A line graph comparing the percentage of patients who improved in pain from baseline (BOCF) between placebo and Duloxetine 60/120 mg once daily. The x-axis shows percent improvement, and the y-axis shows the percentage of patients improved, with Duloxetine showing consistently higher improvement rates across the range compared to placebo.*
Duloxetinedrstructure (Duloxetinedrstructure)
Chemical structure of Duloxetine hydrochloride, showing its molecular arrangement with labeled functional groups and stereochemistry.*
Label Image (Lbl500906040)
Label for Duloxetine delayed-release capsules, 30 mg, supplied by A-S Medication Solutions. The label specifies that each delayed-release capsule contains duloxetine hydrochloride equivalent to 30 mg duloxetine. Storage instructions indicate to store at 68 to 77 degrees Fahrenheit. The package contains 33 unit dose capsules. The label includes the product NDC 50090-6040 and lot number information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
